Ground breaking cancer research finds immune system link

(Medical Xpress)—Curtin University researchers have found evidence that targeting specific cells in the body can reverse the effects of cancer on the immune system.

Dr Connie Jackaman, Early Career Development Fellow at the Curtin Health Innovation Research Institute (CHIRI), is leading a study focused on the capacity of the immune system in older people to deal with cancers.

The research tracked particular cells within the immune system of young and geriatric mice, finding that deterioration, caused by mimicked conditions of lung cancers, could be reduced by activating other cell types.

Dr Jackaman said that the immune system in elderly people, even those who were healthy, was skewed towards but this could be mediated by targeting 'macrophages', a cell found in the immune system.

"The most important outcome from this study was that activating these restored both age-related and tumour-induced ," Dr Jackaman said.

"That is, we could make elderly cells young again by targeting them in the right way, the outcome of which could have real implications for in the elderly."

Although this is the first research undertaken on this topic, the team are confident these findings will have a positive impact on cancer and mesothelioma treatment.

The article was published in the top journal in the field of and geriatrics, Aging Cell. To read the full research article, please visit onlinelibrary.wiley.com/doi/10.1111/acel.12062/pdf

Journal information: Aging Cell
Provided by Curtin University
Citation: Ground breaking cancer research finds immune system link (2013, May 24) retrieved 23 April 2024 from https://medicalxpress.com/news/2013-05-ground-cancer-immune-link.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Anti-CD47 antibody may offer new route to successful cancer vaccination

 shares

Feedback to editors